Moxibustion for Fetus in Breech Presentation

Phase 3

Completed

• Conditions: Breech Presentation
• Interventions: Procedure: Moxibustion of the BL67 acupoint

• Registration Number: NCT00890474
• Lead Sponsor: University Hospital, Geneva

Brief Summary

Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting. The hypothesis is that moxibustion increase the likelihood of cephalic version.

Design: Randomised controlled trial Setting: University hospital. Population: A total of 212 consenting women between 34 and 36 weeks of gestation with a single fetus in breech presentation will be randomised to moxibustion (n=106) or expectant management (n=106).

Main Outcome Measure: Cephalic presentation at delivery or before external cephalic version.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10
• Primary Completion: 2008-12
• Study Completion: 2009-01
• Status Verified: 2009-04
• Study First Submitted: 2009-04-28
• Study First Submitted QC: 2009-04-28
• Last Update Submitted: 2009-04-28
• Study First Posted: 2009-04-29
• Last Update Posted: 2009-04-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 212

Inclusion Criteria

• Breech presentation
• 34 to 36 weeks of gestation
• Single fetus

Exclusion Criteria

• Uterine malformation
• Placenta praevia
• Transverse lie

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Moxibustion	Moxibustion of the BL67 acupoint	-

Primary Outcome Measures

Name	Time	Method
Cephalic presentation at delivery or before external cephalic version	end of pregnancy

Secondary Outcome Measures

Name	Time	Method
Mode of delivery	end of pregnancy
Women's views on the intervention	end of pregnancy
External cephalic version	end of pregnancy

Trial Locations

Locations (1)

Hôpitaux Universitaires de Genève; 🇨🇭 Geneva, Switzerland